Vestibular Autorotation
Test (VAT®) was developed
as a method of evaluating the vestibulo-ocular reflex (VOR) .
* High frequency ( 2-6 Hz) VOR test
(
range of normal everyday locomotion )
* Active
head rotation
* 18 second test
* Tests
both the horizontal and vertical canals
*
Comfortable
* Portable
* Report
Writer
Diagnostic Information
For most of the
population, balance control occurs at an unconscious
level. Signals from the inner ear continuously drive the
eye muscles to coordinate eye movement with head
movement. This coordination is necessary to have clear
vision and balance. The communication between the ear
and the eye is called the vestibulo-ocular reflex (VOR).
When the VOR is functioning properly, eye speed and
timing are equal and opposite to those of the head. But,
if the speed or timing is off, even slightly, vision is
distorted because of apparent motion of the visual
field.
The VAT® is an 18 second test of the high
frequency horizontal and vertical VOR’s for diagnosis,
treatment planning and monitoring of vestibular disease.
The frequency tested ( 2 - 6 Hz) closely approximates
normal head movements. For example, many patients
complain of dizziness or loss of balance when they are
walking, bending over or turning their head quickly. The
VAT® quickly and comfortably monitors a patient’s head
and eye motions to record what is happening in the
vestibular portion of the inner ear.
Testing with the VAT® often identifies
problems not found with other vestibular tests, because
the VAT® tests natural, faster motions and unlike other
conventional vestibular tests, evaluates both the
horizontal and vertical canals. Because the VAT® is
sensitive to changes of the VOR and is easy to perform,
it is often the first screening test a patient receives
who complain of dizziness or balance problems. Patients
do not object to repeated testing which makes the VAT®
the ideal test to monitor ototoxic medication and
vestibular rehabilitation.
The data shown below illustrates the VAT®
test results from a gentamicin ototoxicity patient. The
normative data is shown as the blue error bars ( ± 2
std.) Individual patient VAT® data are shown in various
colors. Notice that both the horizontal and vertical
gains (top two graphs) are well below the normal data.
The horizontal and vertical phases ( bottom two graphs)
are above the normal data. This data pattern is
typically seen in gentamicin
ototoxicity.